Cover Image
Market Research Report
Product code 
948274

Cancer Biomarkers Market Size, By Type (Protein Biomarker, Genetic Biomarker, and Others ), By Cancer Type, By Profiling Technology, By Application, and By Region ; Trend Analysis, Competitive Market Share & Forecast, 2016-26

Published: | Blueweave Consulting & Research Private Limited | 180 Pages | Delivery time: 1-2 business days

Price

Back to Top
Cancer Biomarkers Market Size, By Type (Protein Biomarker, Genetic Biomarker, and Others ), By Cancer Type, By Profiling Technology, By Application, and By Region ; Trend Analysis, Competitive Market Share & Forecast, 2016-26
Published: March 1, 2020
Blueweave Consulting & Research Private Limited
Content info: 180 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

Title:
Cancer Biomarkers Market Size, By Type (Protein Biomarker, Genetic Biomarker, and Others (cell, viral, and carbohydrate biomarkers)), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Bladder Cancer, Kidney Cancer, and Others), By Profiling Technology (Omics Technologies, Imaging Technologies, Bioinformatics, Immunoassays, Cytogenetics, and Others), By Application (Diagnostics, Drug Discovery & Development, Prognostics, Risk Assessment, and Others), and By Region (North America, Europe, Asia Pacific, Middle East & Africa and Latin America); Trend Analysis, Competitive Market Share & Forecast, 2016-26.

According to BlueWeave Consulting, the Global Cancer Biomarkers market has reached USD 13.065 Billion in 2019 and estimated to reach USD 29.45 Billion in 2026, at a CAGR of 12.61% during the forecast period 2020-2026. Rising awareness about the usage of biomarkers at several stages of cancer pushing the market upward.

In addition, lack of physical activities, frequent sun & UV exposure, improper diet, and growing consumption of tobacco are some of the essential factors that have attributed to the escalating prevalence of cancer. Around 22% of cancer deaths are caused due to tobacco consumption and are regarded as the principal risk factor for cancer. Moreover, the growing demand for clinical diagnosis in cancer's early stages and geriatric population base further propels the usage rates of cancer biomarkers. Besides, few internal factors such as hormonal imbalance, genetic mutation, and metabolic mutation contribute towards the surge in cancer cases, which in turn boosts the demand for cancer biomarkers.

Surging utilization of the biomarkers in surrogate endpoints & drug targets developments, increasing interest among researchers & students regarding cancer diagnostic researchers, and need for the biomarkers in cancer research are few crucial success factors for the growth of the global cancer biomarkers market. Most epidemiological studies use biomarkers to examine various stages of human disease. It requires careful handling and storage of sensitive biological samples to obtain a great deal of information from small samples and reduce future research costs by using banked samples.

The genetic biomarker segment in Type is expected to grow at a very high CAGR during the forecast horizon

Based on Type, the genetic biomarker segment is forecasted to dominate during the forecast period, owing to the advancement of technologies to detect the mutation. Gene expression profiling (microarray), Next-generation sequencing (NGS), and polymerase chain reaction (PCR) are the essential technologies used for genetic biomarker discovery and diagnosis. Advancements in high-throughput technologies are the major factors driving the cancer biomarkers market.

Technological advancements

There have been significant technological developments over fields such as diagnostic imaging, immunoassays, omics technologies, and bioinformatics. Using advanced bioinformatics tools, developments in omics technology allow faster acquisition of proteomic, genomic, and metabolomics data and its alliance with clinical trial data. Over the past decade, the omics movement has growing biomarker applications in biomedical research. Additionally, developments in high-throughput genomic technologies facilitate the identification and analysis of key gene mutations and polymorphisms, thereby expanding the spectrum of available genomic biomarkers.

Increased incidence and prevalence of different types of cancer

There is a surge in the cases of cancer among the global population, which has boosted the demand for Cancer Biomarkers. As per the World Health Organization, it is anticipated to increase cancer cases over the next two decades further. Cancer is prevalent largely in lower and middle-income nations since they lack suitable healthcare infrastructure to combat the condition effectively. In addition, the cancer cases were higher in men than in women.

North America is expected to have the lion's share in the global Cancer Biomarkers market during the anticipated period.

By geography, the global Cancer Biomarkers Market segregated into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America is expected to have the lion's share in the global cancer biomarkers market during the forecast period, owing to the adoption of advanced technologies, increasing the number of research studies for the development of novel biomarkers. The existence of a large number of pharmaceutical firms, rising funding and investments from public and private organizations, and the growing use of biomarkers in patient stratification and drug development method.

Table of Contents
Product Code: BWC19432

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Breakdown of Primary Research Respondents, By Region
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Breakdown of Primary Research Respondents
  • 2.5. Market Size Estimation
  • 2.6. Assumption for The Study
  • 2.7. Market Breakdown & Data Triangulation

3. Executive Summary

4. Global Cancer Biomarkers Insights

  • 4.1. DROC Analysis
    • 4.1.1. Growth Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. Technological Landscape
  • 4.3. Regulatory Framework
  • 4.4. Company Market Share Analysis, 2019
  • 4.5. Porter's Five forces analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Intensity of Rivalry

5. Global Cancer Biomarkers Market Overview

  • 5.1. Market Size & Forecast by Value, 2016-2026
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share & Forecast 2016-2026
    • 5.2.1. By Type
      • 5.2.1.1. Protein Biomarker
      • 5.2.1.2. Genetic Biomarker
      • 5.2.1.3. Others (cell, viral, and carbohydrate biomarkers)
    • 5.2.2. By Cancer Type
      • 5.2.2.1. Breast Cancer
      • 5.2.2.2. Lung Cancer
      • 5.2.2.3. Colorectal Cancer
      • 5.2.2.4. Prostate Cancer
      • 5.2.2.5. Thyroid Cancer
      • 5.2.2.6. Bladder Cancer
      • 5.2.2.7. Kidney Cancer
      • 5.2.2.8. Others
    • 5.2.3. By Profiling Technology
      • 5.2.3.1. Omics Technologies
      • 5.2.3.2. Imaging Technologies
      • 5.2.3.3. Immunoassays
      • 5.2.3.4. Cytogenetics
      • 5.2.3.5. Bioinformatics
      • 5.2.3.6. Others
    • 5.2.4. By Application
      • 5.2.4.1. Diagnostics
      • 5.2.4.2. Drug Discovery & Development
      • 5.2.4.3. Prognostics
      • 5.2.4.4. Risk Assessment
      • 5.2.4.5. Others
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia Pacific
      • 5.2.5.4. Latin America
      • 5.2.5.5. Middle East & Africa

6. North America Cancer Biomarkers Market

  • 6.1. Market Size & Forecast by Value, 2016-2026
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast 2016-2026
    • 6.2.1. By Type
    • 6.2.2. By Cancer Type
    • 6.2.3. By Profiling Technology
    • 6.2.4. By Application
    • 6.2.5. By Country
      • 6.2.5.1. U.S
      • 6.2.5.2. Canada

7. Europe Cancer Biomarkers Market

  • 7.1. Market Size & Forecast by Value, 2016-2026
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast 2016-2026
    • 7.2.1. By Type
    • 7.2.2. By Cancer Type
    • 7.2.3. By Profiling Technology
    • 7.2.4. By Application
    • 7.2.5. By Country
      • 7.2.5.1. Germany
      • 7.2.5.2. U.K
      • 7.2.5.3. France
      • 7.2.5.4. Italy
      • 7.2.5.5. Rest of Europe

8. Asia Pacific Cancer Biomarkers Market

  • 8.1. Market Size & Forecast by Value, 2016-2026
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast 2016-2026
    • 8.2.1. By Type
    • 8.2.2. By Cancer Type
    • 8.2.3. By Profiling Technology
    • 8.2.4. By Application
    • 8.2.5. By Country
      • 8.2.5.1. China
      • 8.2.5.2. India
      • 8.2.5.3. Japan
      • 8.2.5.4. South Korea
      • 8.2.5.5. Rest of Asia Pacific

9. Latin America Cancer Biomarkers Market

  • 9.1. Market Size & Forecast by Value, 2016-2026
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast 2016-2026
    • 9.2.1. By Type
    • 9.2.2. By Cancer Type
    • 9.2.3. By Profiling Technology
    • 9.2.4. By Application
    • 9.2.5. By Country
      • 9.2.5.1. Brazil
      • 9.2.5.2. Mexico
      • 9.2.5.3. Argentina
      • 9.2.5.4. Rest of Latin America

10.Middle East & Africa Cancer Biomarkers Market

  • 10.1. Market Size & Forecast by Value, 2016-2026
    • 10.1.1. By Value (USD Billion)
  • 10.2. Market Share & Forecast 2016-2026
    • 10.2.1. By Type
    • 10.2.2. By Cancer Type
    • 10.2.3. By Profiling Technology
    • 10.2.4. By Application
    • 10.2.5. By Country
      • 10.2.5.1. Saudi Arabia
      • 10.2.5.2. UAE
      • 10.2.5.3. South Africa
      • 10.2.5.4. Rest of Middle East & Africa

11.Company Profile (Company Overview, Financial Matrix, Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

  • 11.1. Thermo Fisher Scientific
  • 11.2. Bio-Rad Laboratories
  • 11.3. Roche Diagnostics
  • 11.4. Qiagen N.V.
  • 11.5. Illumina
  • 11.6. G.E. Healthcare
  • 11.7. Agilent Technologies
  • 11.8. Biomerieux SA
  • 11.9. Merck & Co.
  • 11.10. Abbott Laboratories
  • 11.11. Becton, Dickinson, and Company
  • 11.12. Danaher Corporation
  • 11.13. Myriad Genetics
  • 11.14. Sysmex Corporation
  • 11.15. Hologic
  • 11.16. Quest Diagnostics
  • 11.17. Other Prominent Players

List of Figures

Fig: Global Cancer Biomarkers Segmentation

Fig: Company Market Share Analysis, 2019

Fig: Global Cancer Biomarkers Market Size, By Value (USD Billion), 2016-2026

Fig: Global Cancer Biomarkers Market Share, By Type, By Value, 2016-2026

Fig: Global Cancer Biomarkers Market Share, By Cancer Type, By Value, 2016-2026

Fig: Global Cancer Biomarkers Market Share, By Profiling Technology, By Value, 2016-2026

Fig: Global Cancer Biomarkers Market Share, By Application, By Value, 2016-2026

Fig: Global Cancer Biomarkers Market Share, By Region, By Value, 2016-2026

Fig: North America Cancer Biomarkers Market Size, By Value (USD Billion), 2016-2026

Fig: North America Cancer Biomarkers Market Y-o-Y Growth, By Value, 2017-2026

Fig: North America Cancer Biomarkers Market Share, By Type, By Value, 2016-2026

Fig: North America Cancer Biomarkers Market Share, By Cancer Type, By Value, 2016-2026

Fig: North America Cancer Biomarkers Market Share, By Profiling Technology, By Value, 2016-2026

Fig: North America Cancer Biomarkers Market Share, By Application, By Value, 2016-2026

Fig: North America Cancer Biomarkers Market Share, By Country, By Value, 2016-2026

Fig: Europe Cancer Biomarkers Market Size, By Value (USD Billion), 2016-2026

Fig: Europe Cancer Biomarkers Market Y-o-Y Growth, By Value, 2017-2026

Fig: Europe Cancer Biomarkers Market Share, By Type, By Value, 2016-2026

Fig: Europe Cancer Biomarkers Market Share, By Cancer Type, By Value, 2016-2026

Fig: Europe Cancer Biomarkers Market Share, By Profiling Technology, By Value, 2016-2026

Fig: Europe Cancer Biomarkers Market Share, By Application, By Value, 2016-2026

Fig: Europe Cancer Biomarkers Market Share, By Country, By Value, 2016-2026

Fig: Asia-Pacific Cancer Biomarkers Market Size, By Value (USD Billion), 2016-2026

Fig: Asia-Pacific Cancer Biomarkers Market Y-o-Y Growth, By Value, 2017-2026

Fig: Asia-Pacific Cancer Biomarkers Market Share, By Type, By Value, 2016-2026

Fig: Asia-Pacific Cancer Biomarkers Market Share, By Cancer Type, By Value, 2016-2026

Fig: Asia-Pacific Cancer Biomarkers Market Share, By Profiling Technology, By Value, 2016-2026

Fig: Asia-Pacific Cancer Biomarkers Market Share, By Application, By Value, 2016-2026

Fig: Asia-Pacific Cancer Biomarkers Market Share, By Country, By Value, 2016-2026

Fig: Latin America Cancer Biomarkers Market Size, By Value (USD Billion), 2016-2026

Fig: Latin America Cancer Biomarkers Market Y-o-Y Growth, By Value, 2017-2026

Fig: Latin America Cancer Biomarkers Market Share, By Type, By Value, 2016-2026

Fig: Latin America Cancer Biomarkers Market Share, By Cancer Type, By Value, 2016-2026

Fig: Latin America Cancer Biomarkers Market Share, By Profiling Technology, By Value, 2016-2026

Fig: Latin America Cancer Biomarkers Market Share, By Application, By Value, 2016-2026

Fig: Latin America Cancer Biomarkers Market Share, By Country, By Value, 2016-2026

Fig: Middle-East & Africa Cancer Biomarkers Market Size, By Value (USD Billion), 2016-2026

Fig: Middle-East & Africa Cancer Biomarkers Market Y-o-Y Growth, By Value, 2017-2026

Fig: Middle-East & Africa Cancer Biomarkers Market Share, By Type, By Value, 2016-2026

Fig: Middle-East & Africa Cancer Biomarkers Market Share, By Cancer Type, By Value, 2016-2026

Fig: Middle-East & Africa Cancer Biomarkers Market Share, By Profiling Technology, By Value, 2016-2026

Fig: Middle-East & Africa Cancer Biomarkers Market Share, By Application, By Value, 2016-2026

Fig: Middle East & Africa Cancer Biomarkers Market Share, By Country, By Value, 2016-2026

List of Tables:

Table: Global Cancer Biomarkers Market Size, By Type, By Value, 2016-2026

Table: Global Cancer Biomarkers Market Size, By Cancer Type, By Value, 2016-2026

Table: Global Cancer Biomarkers Market Size, By Profiling Technology, By Value, 2016-2026

Table: Global Cancer Biomarkers Market Size, By Application, By Value, 2016-2026

Table: Global Cancer Biomarkers Market Size, By Region, By Value, 2016-2026

Table: North America Cancer Biomarkers Market Size, By Type, By Value, 2016-2026

Table: North America Cancer Biomarkers Market Size, By Cancer Type, By Value, 2016-2026

Table: North America Cancer Biomarkers Market Size, By Profiling Technology, By Value, 2016-2026

Table: North America Cancer Biomarkers Market Size, By Application, By Value, 2016-2026

Table: North America Cancer Biomarkers Market Size, By Country, By Value, 2016-2026

Table: Europe Cancer Biomarkers Market Size, By Type, By Value, 2016-2026

Table: Europe Cancer Biomarkers Market Size, By Cancer Type, By Value, 2016-2026

Table: Europe Cancer Biomarkers Market Size, By Profiling Technology, By Value, 2016-2026

Table: Europe Cancer Biomarkers Market Size, By Application, By Value, 2016-2026

Table: Europe Cancer Biomarkers Market Size, By Country, By Value, 2016-2026

Table: Asia-Pacific Cancer Biomarkers Market Size, By Type, By Value, 2016-2026

Table: Asia-Pacific Cancer Biomarkers Market Size, By Cancer Type, By Value, 2016-2026

Table: Asia-Pacific Cancer Biomarkers Market Size, By Profiling Technology, By Value, 2016-2026

Table: Asia-Pacific Cancer Biomarkers Market Size, By Application, By Value, 2016-2026

Table: Asia-Pacific Cancer Biomarkers Market Size, By Country, By Value, 2016-2026

Table: Latin America Cancer Biomarkers Market Size, By Type, By Value, 2016-2026

Table: Latin America Cancer Biomarkers Market Size, By Cancer Type, By Value, 2016-2026

Table: Latin America Cancer Biomarkers Market Size, By Profiling Technology, By Value, 2016-2026

Table: Latin America Cancer Biomarkers Market Size, By Application, By Value, 2016-2026

Table: Latin America Cancer Biomarkers Market Size, By Country, By Value, 2016-2026

Table: Middle-East & Africa Cancer Biomarkers Market Size, By Type, By Value, 2016-2026

Table: Middle-East & Africa Cancer Biomarkers Market Size, By Cancer Type, By Value, 2016-2026

Table: Middle-East & Africa Cancer Biomarkers Market Size, By Profiling Technology, By Value, 2016-2026

Table: Middle-East & Africa Cancer Biomarkers Market Size, By Application, By Value, 2016-2026

Table: Middle East & Africa Cancer Biomarkers Market Size, By Country, By Value, 2016-2026

Table: Thermo Fisher Scientific Financial Analysis

Table: Bio-Rad Laboratories Financial Analysis

Table: Roche Diagnostics Financial Analysis

Table: Qiagen N.V. Financial Analysis

Table: G.E. Healthcare Financial Analysis

Table: Agilent Technologies Financial Analysis

Table: Biomerieux SA Financial Analysis

Table: Merck & Co. Financial Analysis

Table: Abbott Laboratories Financial Analysis

Table: Danaher Corporation Financial Analysis